KPIs & Operating Metrics(New)
Adjusted Ebitda By SegmentAdjusted Ebitda By Segment AnnualAdjusted Ebitda Margin By Segment %Adjusted Ebitda Margin By Segment Annual %Average Pmpm By Product TypeAverage Pmpm Fees / Revenue Per Case By SegmentAverage Unique MembersAverage Unique Members AnnualAverage Yield Per CaseBreakdown Of AssetsContractual ObligationsCost Of RevenueDeferred RevenueEmployee StatisticsGross Margin %Gross ProfitIncome (Loss) Before Income Tax By RegionLives By Product TypeLives Managed By SegmentLives On Platform/ Cases During Period By SegmentNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Opex As A % Of Total Revenue %OPEX SegregationProperty And Equipment, NetRemaining Performance ObligationsRemaining Performance Obligations AnnualRevenue By Business VerticalRevenue By Business Vertical %Revenue By Business Vertical AnnualRevenue By Business Vertical Annual %Revenue By End MarketRevenue By End Market %Revenue By End Market AnnualRevenue By End Market Annual %Revenue By Product TypeRevenue By Product Type %Revenue By Product Type AnnualRevenue By Product Type Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %Total Cases ManagedTotal Lives ManagedTotal Lives On Platform
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Evolent Health (EVH) Gross Profit (2015 - 2026)

Evolent Health's quarterly Gross Profit came in at $83.8 million in Q1 2026, down 18.25% year-on-year from $102.5 million in Q1 2025, and down 13.86% quarter-over-quarter from $97.3 million in Q4 2025.

Evolent Health has reported Gross Profit for 12 years, with the latest figure at $83.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Gross Profit fell 18.25% year-over-year to $83.8 million; the trailing twelve-month figure through Mar 2026 stood at $381.2 million (up 4.23% YoY), and the FY2025 full-year result was $399.9 million, up 8.86% from the prior year.
  • Gross Profit for Q1 2026 stood at $83.8 million, down from $97.3 million in the prior quarter.
  • The five-year high for Gross Profit was $124.4 million in Q3 2023, with the low at $70.2 million in Q2 2022.
  • Average Gross Profit over 5 years is $95.8 million, with a median of $99.8 million recorded in 2025.
  • Year-over-year, Gross Profit surged 66.87% in 2023 and tumbled 35.15% in 2024.
  • Tracing EVH's Gross Profit over 5 years: stood at $83.1 million in 2022, then advanced by 22.35% to $101.6 million in 2023, then decreased by 25.5% to $75.7 million in 2024, then gained by 28.45% to $97.3 million in 2025, then slipped by 13.86% to $83.8 million in 2026.
  • The last three Gross Profit figures came in at $83.8 million (Q1 2026), $97.3 million (Q4 2025), and $99.8 million (Q3 2025), per Business Quant data.